Gabather, Joins

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Gabather AB Sweden

View original content:https://www.prnewswire.co.uk/news-releases/gabather-joins-forces-with-the-centre-for-neuropsychiatric-schizophrenia-research-in-denmark-to-conduct-a-clinical-phase-ii-study-with-gt-002-302113057.html

en | CA7609751028 | GABATHER | boerse | 67932290 |